CD80 (Galiximab Biosimilar) Antibodies
(CD80 (Galiximab Biosimilar))
The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended CD80 (Galiximab Biosimilar) Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
IP, WB, BR, ELISA, FACS, IHC
Validations
- (1)
Cat. No.
ABIN7072388
Quantity
200 μg
Datasheet
Datasheet
Reactivity
Human
Application
IP, WB, BR, ELISA, FACS, IHC
Validations
Cat. No.
ABIN7072387
Quantity
200 μg
Datasheet
Datasheet
Synonyms and alternative names related to CD80 (Galiximab Biosimilar)
CD80 molecule (CD80), B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7Protein level used designations for CD80 (Galiximab Biosimilar)
- B-lymphocyte activation antigen B7
- CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)
- CTLA-4 counter-receptor B7.1
- T-lymphocyte activation antigen CD80
- activation B7-1 antigen
- costimulatory factor CD80
- costimulatory molecule variant IgV-CD80
You are here:
